Hong Kong, China vs Iran, Islamic Republic of: Treatment success rate for patients treated for MDR-TB

Hong Kong, China
72.0%
in 2022
Iran, Islamic Republic of
72.0%
in 2022
Hong Kong, China rank
87th
Iran, Islamic Republic of rank
87th

Treatment success rate for patients treated for MDR-TB over time

  • Hong Kong, China
  • Iran, Islamic Republic of
20406080100200220122022

How they compare

Hong Kong, China currently reports 72.0% against 72.0% in Iran, Islamic Republic of, a difference of 0.0%.

The two have swapped places 7 times across 18 shared years of data; in 2002 it was Hong Kong, China ahead.

Hong Kong, China ranks 87th and Iran, Islamic Republic of ranks 87th of 163 countries.

Hong Kong, China has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Hong Kong, China Iran, Islamic Republic of Difference Ahead
2000s 63.8% 37.0% 26.8% Hong Kong, China
2010s 70.8% 58.0% 12.8% Hong Kong, China
2020s 80.0% 68.3% 11.7% Hong Kong, China

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment success rate for patients treated for mdr-tb, Hong Kong, China or Iran, Islamic Republic of?
Hong Kong, China, at 72.0% against 72.0% in Iran, Islamic Republic of as of 2022.
What is the difference in treatment success rate for patients treated for mdr-tb between Hong Kong, China and Iran, Islamic Republic of?
0.0%, with Hong Kong, China ahead.
How many years of comparable data are there for Hong Kong, China and Iran, Islamic Republic of?
18 years are reported by both, from 2002 to 2022.
How do Hong Kong, China and Iran, Islamic Republic of rank globally for treatment success rate for patients treated for mdr-tb?
Hong Kong, China ranks 87th and Iran, Islamic Republic of ranks 87th of 163 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Hong Kong, China vs Iran, Islamic Republic of: Treatment success rate for patients treated for MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 17 September 2026, from https://health.statizoid.com/compare/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/hong-kong-sar-china/iran-islamic-rep/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/hong-kong-sar-china/iran-islamic-rep/">Hong Kong, China vs Iran, Islamic Republic of: Treatment success rate for patients treated for MDR-TB</a> — Statizoid

About this data

Indicator
Treatment success rate for patients treated for MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
175 places, 2,495 data points, 1999–2022
Last refreshed